4528
Ono Pharmaceutical Co., Ltd.
2026/02/02
For FY2026 Q3, revenue was 397.0 billion yen (6.0% YoY increase), operating income was 88.2 billion yen (24.8% YoY increase), and quarterly profit was 68.9 billion yen (21.8% YoY increase).
